MYP_002816
Basic Information
T21N23
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
46 amino acids
C249H417N79O68
Standard
Sequence
RIQQIEQKIHHIEQRIQQIEQRAIEAQQHLLQLTVWGIKQLQARIL
Physicochemical Analysis
5605.46 Da
9.97
2.03
1.67
0.0441
-0.53
0.64
-0.12
101.06
131.52
0.0217
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
2460.80
-19.83
82.0
73.0
201.0
396.0
5.0
57.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0071410 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV-1
RECORD: Rec_0178458 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Disulfide bond(s) reported
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1(human immunodeficiency virus 1):inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells
0.0389±0.0358 μM
IC50
RECORD: Rec_0291782 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 (human immunodeficiency virus 1) | TZM-bl cells; HL2/3 cells
0.0389±0.0358 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min